Very few data exist on the occurrence of acute kidney injury (AKI) associated with transcatheter aortic valve implantation (TAVI). The objectives of the present study were (i) to determine the incidence, predictive factors, and prognostic value of AKI following TAVI, and (ii) to compare the occurrence of AKI in TAVI vs. surgical aortic valve replacement (SAVR) in patients with pre-procedural chronic kidney disease (CKD).
Introduction
Acute kidney injury (AKI) is one of the most serious complications following cardiac surgery, with an incidence varying between 1 and 30% depending on the definition of AKI and baseline characteristics of the study population. 1 Several studies have shown that the occurrence of AKI after cardiac surgery is an independent predictor of in-hospital, mid-and long-term mortality, with a two-to three-fold increase in the risk of death in those patients presenting AKI following the intervention. 1 -4 Surgical aortic valve replacement (SAVR) is the gold standard for the treatment of symptomatic severe aortic stenosis (AS), and transcatheter aortic valve implantation (TAVI) has emerged as an alternative treatment for those patients considered at very high or prohibitive surgical risk. 5 -8 Patients undergoing TAVI nowadays are thus commonly very old and have a high prevalence of chronic kidney disease (CKD). In fact, trying to avoid potential deterioration of renal function in patients with CKD has become an important argument for choosing TAVI rather than SAVR in those cases. However, very few data exist on the occurrence and prognosis of AKI following TAVI, 9 and no studies have as yet determined whether a TAVI strategy is associated with a lower incidence of AKI compared with SAVR. TAVI procedures involve the administration of contrast media, the systematic occurrence of short periods of extreme hypotension (rapid pacing, balloon valvuloplasty, and valve deployment), and the manipulation of large catheters in the aorta of patients with a high prevalence of diffuse atherosclerosis with the risk of cholesterol embolization, all of them are potential risk factors for AKI. Therefore, the objectives of this study were (i) to determine the incidence, predictive factors, and prognostic value of AKI following TAVI, and (ii) to compare the occurrence of AKI in TAVI vs. SAVR in the subset of patients with pre-procedural CKD. Transcatheter aortic valve implantation and surgical aortic valve replacement procedures TAVI procedures have been described in detail in previous reports.
Methods Patients
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The Cribier -Edwards or Edwards-SAPIEN valve (Edwards Lifesciences Inc., Irvine, CA, USA) was used in all cases either by transfemoral (n ¼ 111, 52%) or transapical (n ¼ 102, 48%) approach. Patients with preprocedural CKD received intravenous hydration before and after the procedure, and the use of a prophylactic treatment (N-acetylcysteine, intravenous bicarbonate) was left at the discretion of the physician performing the procedure. The amount of contrast, number of rapid pacing runs, the occurrence of any complication leading to severe maintained hypotension, and/or the need for haemodynamic support (aortic counterpulsation balloon and extracorporeal circulation) were recorded. A successful procedure was defined as the implantation of a functioning prosthetic valve within the aortic annulus at the end of the procedure without in-laboratory mortality. SAVR procedures were performed through mid-sternotomy, using standard surgical techniques and under extracorporeal circulation.
Serum creatinine measurements and acute kidney injury definition
All patients in both TAVI and SAVR groups had a systematic determination of serum creatinine and eGFR calculation based on the simplified modification of diet in renal disease (MDRD) formula 11 before (,7 days) and at 48 h following the procedure. The occurrence of AKI was defined as a decrease of .25% in eGFR at 48 h following the procedure (RIFLE criteria), 12 or the need of haemodialysis during index hospitalization. The degree of AKI was further classified as (i) .25% decrease in eGFR, (ii) 50 -75% decrease in eGFR, and (iii) .75% decrease in eGFR.
Statistical analysis
Qualitative variables were expressed as percentages and quantitative variables as mean (standard deviation) or median (interquartile range). The normality distribution for continuous data was examined with the Shapiro -Wilk test. Comparison of numerical variables was performed using the two-sided Student's t-test or Wilcoxon rank-sum test, and the chi-square or Fischer's exact tests were used to compare qualitative variables. A stepwise logistic regression analysis including all variables with P-value , 0.2 in the univariate analysis was used to determine the predictive factors of both AKI and hospital mortality. The following variables were included in the model for the prediction of AKI: age, hypertension, chronic obstructive pulmonary disease, logistic EuroSCORE, procedural approach (transfemoral vs. transapical), procedural time, contrast media volume, any complication leading to the need of haemodynamic support, red blood cell (RBC) transfusion, and post-procedural myocardial infarction. The variables included in the model for the prediction of in-hospital death were: male gender, cerebrovascular disease, peripheral vascular disease, chronic obstructive pulmonary disease, pre-procedural serum creatinine, logistic EuroSCORE, left ventricular ejection fraction, preprocedural mean aortic gradient, pulmonary artery pressure, procedural approach, contrast media volume, RBC transfusion, number of RBC units, post-procedural stroke, post-procedural pneumonia or sepsis, serum creatinine and eGFR at 48 h post-procedure, and AKI. A continuous propensity score analysis was performed to adjust for the intergroup (TAVI vs. SAVR in patients with CKD) differences in baseline clinical characteristics caused by the selection bias inherent to the nonrandomized nature of the study. A propensity score representing the likelihood of having TAVI as opposed to SAVR was calculated for each patient by using a logistic regression analysis that identified variables independently associated with the type of procedure. Variables exhibiting a P-value , 0.2 in the univariate analysis were included in the logistic regression analysis. The variables used for the propensity score were: age, logistic EuroSCORE, congestive heart failure, coronary artery disease, peripheral vascular disease, and baseline eGFR. In addition, the incidence of post-procedural AKI was further evaluated after patient matching based on pre-procedural eGFR values between TAVI and SAVR groups. Differences were considered statistically significant at P-values , 0.05. The data were analysed using SAS statistical software version 9.1.3 (SAS Institute Inc., Cary, NC, USA).
Results
Baseline clinical and echocardiographic characteristics of the study population and the main TAVI peri-procedural characteristics are shown in Table 1 . Acute kidney injury occurred in 25 patients (11.7%) and 3 patients (1.4%) required dialysis during index hospitalization. The changes in eGFR at 48 h following TAVI are shown in Table 1 and Figure 1 .
Predictive factors of acute kidney injury
Baseline and procedural characteristics of the study population grouped according to the occurrence of AKI are shown in Acute kidney injury 25 (12) Values are expressed as n (%) or mean + SD unless otherwise noted. eGFR, estimated glomerular filtration rate.
The independent predictors of AKI following the procedure are shown in Table 3 .
Acute kidney injury and hospital mortality
Hospital mortality occurred in 21 patients (9.8%). In those patients presenting AKI, the mortality rate was 28% compared with 7.4% in those patients with no AKI (P ¼ 0.005; P , 0.0001 after including in the analysis the eight patients who died within the 24 h following the procedure and for which post-procedural creatinine value could not be assessed). Table 4 shows the clinical and periprocedural characteristics of the patients who died in the postoperative period compared with those who survived. Patients who died had more frequently a history of chronic obstructive pulmonary disease (52 vs. 30%, P ¼ 0.049), had a higher logistic Euro-SCORE (40.5 + 21.3 vs. 28.1 + 16.7%, P ¼ 0.001) and exhibited higher levels of pulmonary artery systolic pressure (56 + 14 vs. 50 + 12 mmHg, P ¼ 0.033). The independent predictive factors of hospital mortality are shown in Table 5 .
Acute kidney injury in transcatheter aortic valve implantation vs. surgical aortic valve replacement procedures
The clinical and procedural characteristics of patients with preprocedural CKD grouped according to the type of procedure (TAVI vs. SAVR) are shown in Figure 2 .
Discussion
Acute kidney injury occurred in 11.7% of the patients following TAVI, with 1.4% of them requiring dialysis. A history of hypertension, chronic obstructive pulmonary disease, and peri-operative blood transfusion were predictive factors of AKI. Patients who presented AKI had a hospital mortality of 28%, and the occurrence of AKI was an independent predictor of mortality, with greater than four-fold increase in the risk of postoperative death among those patients presenting AKI after TAVI. In patients with severe symptomatic AS and pre-procedural CKD, the incidence of AKI was lower in those who underwent TAVI compared with those who underwent SAVR ( ) and the amount of contrast media used during the procedure was higher (mean .200 cc). All these factors might have contributed to the higher rate of AKI following TAVI in that study. The presence of hypertension has been associated with impaired kidney autoregulation which increases the risk of AKI despite maintaining mean arterial pressure within the normal range. 13 Hsu et al. 14 reported that hypertension increased the risk of nosocomial AKI in patients with CKD. Also, hypertension was shown to be an independent predictor of AKI following cardiothoracic surgery and percutaneous coronary intervention. 15, 16 Chronic obstructive pulmonary disease has been shown to be an independent predictor of AKI in patients undergoing cardiac surgery, 1, 17 and the present study also demonstrated that this comorbidity increased the risk of AKI following TAVI by greater than two-fold. Anand et al. 18 reported that patients with chronic obstructive pulmonary disease may experience a significant reduction in renal blood flow and glomerular filtration. Also, chronic obstructive pulmonary disease patients are more prone to the occurrence of episodes of severe hypoxemia -hypercapnia during the peri-operative period and this might indeed have contributed to further deterioration of renal function. 19 The need for RBC transfusion is a very well recognized predictor of AKI following cardiac surgery. 4, 20 Consistent with our results, Aregger et al. recently showed that the number of blood transfusions was also associated with an increased risk of AKI following TAVI. Preserved RBCs undergo progressive functional and structural changes leading to a reduction in RBC function and viability, and accumulate proinflammatory molecules, free iron, and haemoglobin, and all these changes might favour renal dysfunction, particularly in older patients with impairment of kidney autoregulation. 20, 21 The present study showed that up to half of the patients undergoing TAVI had received RBC transfusion and that this was associated Continued with a greater than three-fold increase in the risk of AKI. This result suggests that efforts should be made to avoid unnecessary blood transfusions in patients undergoing TAVI. Interestingly, the amount of contrast media was not associated with AKI following TAVI. A contrast volume .100 cc has been associated with contrast-induced nephropathy following percutaneous coronary intervention. 22 -24 The fact that the mean contrast volume used in the present study was ,100 cc might partially explain the lack of correlation. Nonetheless, continued efforts to minimize the amount of contrast media in these procedures (contrast dilution, contrast hand injections, and echocardiography guiding for valve positioning 25 ) would be important to further reduce the risk of AKI following TAVI. Finally, we found no correlation between the number of rapid pacing runs and the occurrence of AKI, and this suggests that the short periods of severe hypotension induced by rapid pacing do not play an important role in the deterioration of renal function following TAVI. However, the fact that the rapid pacing technique was used in all patients limits our ability to completely rule out a potential role for such short periods of hypotension in AKI following TAVI.
Acute kidney injury and hospital mortality
Several studies have shown AKI to be a powerful predictor of death at short-, mid-, and long-term follow-up after cardiothoracic surgery and percutaneous coronary intervention. 1 -4,24 The present study is the first to demonstrate that AKI is associated with a higher (four-fold) postoperative mortality following TAVI and that this association was independent of baseline risk profile characteristics and peri-procedural complications. The pathophysiology explaining the prognostic role of AKI in the early postoperative period of TAVI remains unclear. Although AKI could have been only a marker of multisystem failure, our results showed that the high mortality rate in patients with AKI cannot be fully attributed to comorbidities or peri-procedural complications, which suggests that AKI contributes directly to early postoperative mortality. These results highlight the clinical relevance of assessing kidney function within the 48 h following TAVI in order to identify those patients who complicate with AKI and thereby require close follow-up during the postprocedural period.
Surgical aortic valve replacement vs. transcatheter aortic valve implantation in patients with pre-procedure chronic kidney disease
Patients with preoperative CKD undergoing cardiac surgery are at high risk of AKI and dialysis following the operation. 1 Gummert et al. 26 showed that up to 16% of the patients with CKD undergoing SAVR required haemodialysis during the postoperative period. The results of the present study showed that in patients with previous renal dysfunction, the occurrence of AKI was lower with TAVI (9.2%) compared with SAVR (25.9%). Also, TAVI was associated with a non-significant reduction in the need for haemodialysis following the intervention compared with SAVR. Interestingly, eGFR improved in most CKD patients undergoing TAVI compared with less than half of the patients undergoing SAVR. obtained with TAVI in the high-risk subset of CKD patients with severe AS. Future prospective randomized studies such as the Placement of AoRTic TraNscathetER Valve (PARTNER) trial should confirm these results and determine whether the sole presence of CKD should be used as a criterion to select TAVI rather than SAVR in patients with symptomatic severe AS.
Study limitations
The results of this study were obtained from a database with prospectively gathered data. However, this was a post hoc non-pre-specified analysis and we cannot rule out the possibility that other potential confounding variables not included in the model might have affected the results. Also, the results were based on a single determination of eGFR at 48 h following the procedure. We cannot exclude the possibility that further measurements of creatinine levels during the hospitalization period might have revealed a higher incidence of AKI. Due to the nonrandomized nature of the study, differences in the occurrence of AKI between TAVI and SAVR should be seen as hypothesis generating and will need to be confirmed by prospective randomized studies. Finally, these results may not apply to lower volume centres, especially at the beginning of the learning curve. Values are expressed as n (%) or mean + SD unless otherwise noted. TAVI, transcatheter aortic valve implantation; SAVR, surgical aortic valve replacement; eGFR, estimated glomerular filtration rate. *P-value corresponds to all sets of variables, No change in eGFR, Decrease in eGFR, 25%, .25%, and Increase in eGFR.
Conclusions
Acute kidney injury occurred in only 11.7% of the patients undergoing TAVI despite advanced age (mean .80 years) and the very high-risk clinical profile of the study population. Nonetheless, AKI was a very powerful predictor of death during the postoperative period independently of baseline comorbidities and periprocedural complications, and this highlights the importance of both preventing and identifying such a complication early after TAVI. Patients with hypertension and chronic obstructive pulmonary disease and those receiving RBC transfusions were at higher risk, suggesting that a more careful monitoring of patients with these risk factors and a more restrictive strategy regarding blood transfusion during TAVI might be clinically relevant. Finally, in the high-risk group of patients with advanced age, symptomatic severe AS, and pre-procedural chronic kidney disease, TAVI was associated with greater than two-fold lower incidence of postoperative AKI compared with SAVR. Future randomized studies are needed to confirm these results and determine whether their prognostic relevance should lead to the favouring of TAVI in this particular subset of patients.
